Subtype
Lung Carcinoma
CI-CAN-00001086Explore in graph →
2,130 active trials51 approved drugs598 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001086Explore in graph →
Clinical trials
7,792 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,179)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01463423 | Individualized Lung Tumor Stereotactic Ablative Radiotherapy (iSABR) | completed | N/A | 256 | Stanford UniversityOTHER | 3 | Dec 19, 2024 | clinicaltrials |
| NCT06705465 | Cross-sectorial Rehabilitation of Patients with Lung Cancer | recruiting | N/A | 130 | Camilla BalleOTHER | 1 | Dec 18, 2024 | clinicaltrials |
| NCT06739421 |
| The Diagnostic Value of Bronchoscopic Needle-based Confocal Laser Endomicroscopy (nCLE) As a Real-time Detection Tool for Diagnosing Peripheral Lung Cancer: a Multi-centre Randomised Controlled Trial |
| not yet recruiting |
| N/A |
| 1,040 |
| China-Japan Friendship HospitalOTHER |
| 1 |
| Dec 18, 2024 |
| clinicaltrials |
| NCT02515760 | Tumor-specific T Cells in Lung Cancer | active not recruiting | N/A | 120 | University Hospital HeidelbergOTHER | 1 | Dec 12, 2024 | clinicaltrials |
| NCT05094544 | Pre-Operative Immuno-Modulatory SBRT (POIMS Trial): A Pilot Trial in Early Stage NSCLC(POIMS) | withdrawn | N/A | 0 | University of Kansas Medical CenterOTHER | 1 | Dec 12, 2024 | clinicaltrials |
| NCT05304390 | A Tailored Screening and Smoking Cessation Program for the LGBTQ Community of Seattle | terminated | N/A | 53 | Fred Hutchinson Cancer CenterOTHER | 1 | Dec 2, 2024 | clinicaltrials |
| NCT06709274 | Minimal Residual Disease Guiding Adjuvant Therapy in Stage I NSCLC(MOTION-NSCLC) | not yet recruiting | N/A | 342 | Guangdong Association of Clinical TrialsOTHER | 1 | Nov 29, 2024 | clinicaltrials |
| NCT04629300 | Supportive Care Mobile Application for Patients With NSCLC | completed | N/A | 120 | Massachusetts General HospitalOTHER | 1 | Nov 22, 2024 | clinicaltrials |
| NCT02488850 | Determination of Peripheral Immune Cell Activity During Treatment With Either Surgery or Radiotherapy in Patients With Early Stage NSCLC(HAMLET) | completed | N/A | 32 | Erasmus Medical CenterOTHER | 1 | Nov 7, 2024 | clinicaltrials |
| NCT05347797 | Clinical Study Testing DNA Extracted From Tumour Tissue Biopsy Samples, Using the Therascreen® KRAS RGQ PCR Kit | completed | N/A | 495 | QIAGEN Gaithersburg, IncINDUSTRY | 1 | Nov 4, 2024 | clinicaltrials |
| NCT05348187 | Clinical Performance Study Protocol for Therascreen® KRAS RGQ PCR Kit | completed | N/A | 309 | QIAGEN Gaithersburg, IncINDUSTRY | 1 | Nov 4, 2024 | clinicaltrials |
| NCT05304793 | Testing a Cognitive Behavioral Model for Reducing Dyspnea in Patients With Lung Cancer | completed | N/A | 46 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Oct 31, 2024 | clinicaltrials |
| NCT06646770 | SEgmentectomy Versus Lobectomy in T1C Non-Small Cell Lung Cancer (SELTIC)(SELTIC) | not yet recruiting | N/A | 400 | Istanbul University - CerrahpasaOTHER | 1 | Oct 17, 2024 | clinicaltrials |
| NCT06643910 | A Study on the Safety and Efficacy of BST08 in Treating Advanced Non-Small Cell Lung Cancer | not yet recruiting | N/A | 12 | BioSyngen Pte LtdINDUSTRY | 1 | Oct 16, 2024 | clinicaltrials |
| NCT06028412 | Comparison of Sublobar and Lobectomy in Small (2 Cm or Less 0.5<CTR<1) Non-small Cell Lung Cancer: a Prospective, Multicenter Randomized Controlled Study | enrolling by invitation | N/A | 660 | Xiaolong Yan, Dr.OTHER | 1 | Oct 15, 2024 | clinicaltrials |
| NCT05569291 | Investigating the Feasibility of a Physical Activity (tele)coaching Intervention in Patients with Non-small Cell Lung Cancer: an Explorative Study(LUCA-coach) | completed | N/A | 19 | Hasselt UniversityOTHER | 1 | Oct 4, 2024 | clinicaltrials |
| NCT06406166 | Lifei Xiaoji Wan in Treatment of Advanced NSCLC | unknown | N/A | 100 | Henan University of Traditional Chinese MedicineOTHER | 1 | Sep 25, 2024 | clinicaltrials |
| NCT05557552 | Sequential Chemo-immunotherapy Plus Thoracic Radiotherapy for Elderly And/or Frail Stage III Non-small-cell Lung Cancer | recruiting | N/A | 56 | Ruijin HospitalOTHER | 1 | Sep 23, 2024 | clinicaltrials |
| NCT06607926 | Neoadjuvant With Tα1 Plus Immuno-chemotherapy for Resectable NSCLC | not yet recruiting | N/A | 40 | Xuanwu Hospital, BeijingOTHER | 1 | Sep 23, 2024 | clinicaltrials |
| NCT05902260 | The Effects of an Nutritional Intervention on PD-1 ICI in NSCLC(NutriCim) | completed | N/A | 51 | Joachim Aerts, MD PhDOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06598839 | Immuno-effect of Tα1 for Stage I NSCLC | recruiting | N/A | 40 | Yousheng MaoOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT06481566 | Efficacy and Safety of Almonertinib Combined With Stereotactic Body Radiotherapy (SBRT) in the Treatment of Non-small Cell Lung Cancer With EGFR Sensitive Mutation: a Single-arm, Open-label Clinical Trial | unknown | N/A | 30 | Chongqing University Cancer HospitalOTHER | 1 | Sep 4, 2024 | clinicaltrials |
| NCT02492867 | A Pilot Study of Response-Driven Adaptive Radiation Therapy for Patients With Locally Advanced Non-Small Cell Lung Cancer | completed | N/A | 49 | University of Michigan Rogel Cancer CenterOTHER | 1 | Sep 3, 2024 | clinicaltrials |
| NCT06580665 | Cryoablation with or Without Serplulimab in Treating Patients with Stage I-IIA Non-small Cell Lung Cancer | not yet recruiting | N/A | 134 | Shanghai Chest HospitalOTHER | 1 | Aug 30, 2024 | clinicaltrials |
| NCT06428422 | The Impact of Probiotic on Survival and Treatment Response in Metastatic Non-small Cell Lung Cancer Patients | recruiting | N/A | 100 | Necmettin Erbakan UniversityOTHER | 1 | Aug 16, 2024 | clinicaltrials |
| NCT05805319 | Dietary Intervention for NSCLC Patients Treated With ICI | unknown | N/A | 80 | Centre hospitalier de l'Université de Montréal (CHUM)OTHER | 1 | Aug 12, 2024 | clinicaltrials |
| NCT05987345 | Trial of Pulsed Electric Field Therapy in Patients With Late-stage Non-small Cell Lung Cancer | unknown | N/A | 10 | Energenx Medical LTD.INDUSTRY | 1 | Jul 22, 2024 | clinicaltrials |
| NCT04732520 | Feasibility Study of the Aliya System in the Treatment of Early Stage Non-small Cell Lung Cancer(INCITE ES) | completed | N/A | 47 | Galvanize Therapeutics, Inc.INDUSTRY | 3 | Jul 19, 2024 | clinicaltrials |
| NCT05837429 | Low Volume High Intensity Interval Training in Operated Lung Cancer Patients | unknown | N/A | 40 | Hacettepe UniversityOTHER | 1 | Jul 18, 2024 | clinicaltrials |
| NCT01456429 | Assessment of Invasive Mediastinal Staging in cN1 Lung Cancer.(ASTER2) | unknown | N/A | 100 | Universitaire Ziekenhuizen KU LeuvenOTHER | 2 | Jul 15, 2024 | clinicaltrials |
| NCT05371899 | Mass Balance Study of [14C]Chiauranib | completed | N/A | 6 | Chipscreen Biosciences, Ltd.INDUSTRY | 1 | Jul 15, 2024 | clinicaltrials |
| NCT06479005 | ETERNALS: Remote Monitoring in Lung Cancer Patients(ETERNALS) | unknown | N/A | 50 | Ziekenhuis Oost-LimburgOTHER | 1 | Jul 1, 2024 | clinicaltrials |
| NCT06462105 | Liposomal Irinotecan Combination Regimen for First-line Treatment of Small Cell Lung Cancer | not yet recruiting | N/A | 60 | Zhou ChengzhiOTHER | 0 | Jun 28, 2024 | clinicaltrials |
| NCT02408406 | PatientCareAnywhere Internet-Based Software in Improving Communication and Education in Patients With Cancer and Their Healthcare Providers | completed | N/A | 140 | City of Hope Medical CenterOTHER | 1 | Jun 27, 2024 | clinicaltrials |
| NCT06476093 | SRT Combined With Anlotinib for the Treatment of Brain Metastases From Non-small Cell Lung Cancer | recruiting | N/A | 46 | The First People's Hospital of LianyungangOTHER | 1 | Jun 26, 2024 | clinicaltrials |
| NCT03769129 | Evaluating the Safety and Efficacy of Pembrolizumab Combined With MWA for Advanced NSCLC | recruiting | N/A | 100 | Second Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | Jun 25, 2024 | clinicaltrials |
| NCT02840227 | The Effect of Combined General/Regional Anesthesia on Cancer Recurrence in Patients Having Lung Cancer Resections | withdrawn | N/A | 0 | The Cleveland ClinicOTHER | 1 | Jun 20, 2024 | clinicaltrials |
| NCT05818449 | Improvement of Personalized Lung Cancer Care Through Digital Connection and Patient Participation (DigiNet)(DigiNet) | unknown | N/A | 850 | University of CologneOTHER | 1 | Jun 4, 2024 | clinicaltrials |
| NCT04079595 | Closed vs. Open Face Masks for Cranial Radiotherapy | completed | N/A | 60 | University of ZurichOTHER | 1 | May 23, 2024 | clinicaltrials |
| NCT06406608 | Patient-derived Organoid Drug Sensitivity Guided Treatment for Drug-resistant Recurrent Non-Small Cell Lung Cancer | unknown | N/A | 20 | Henan Cancer HospitalOTHER_GOV | 1 | May 9, 2024 | clinicaltrials |
| NCT06406660 | Patient-derived Organoid Drug Sensitivity Guided Treatment for Recurrent Small Cell Lung Cancer | unknown | N/A | 20 | Henan Cancer HospitalOTHER_GOV | 1 | May 9, 2024 | clinicaltrials |
| NCT04324437 | eRAPID: Online Symptom Reporting in Lung Cancer | completed | N/A | 43 | University of LeedsOTHER | 1 | May 8, 2024 | clinicaltrials |
| NCT06404164 | Pulmonary Watershed Topographic Map Navigation for Lung Nodule Resection | recruiting | N/A | 3,000 | Guangdong Provincial People's HospitalOTHER | 1 | May 8, 2024 | clinicaltrials |
| NCT02760225 | Pembrolizumab-PET Imaging | completed | N/A | 18 | University Medical Center GroningenOTHER | 1 | May 3, 2024 | clinicaltrials |
| NCT06374160 | Exercise in Patients With Advanced Non-small Cell Lung Cancer(BREATH) | unknown | N/A | 104 | University Hospital, EssenOTHER | 1 | Apr 18, 2024 | clinicaltrials |
| NCT06364046 | Efficacy and Safety of DEB-BACE Combined With Serplulimab in First-line Treatment of SCLC | unknown | N/A | 56 | The Central Hospital of Lishui CityOTHER | 1 | Apr 15, 2024 | clinicaltrials |
| NCT05412875 | Pilot Trial of E Cigarettes in Pts Diagnosed With Cancer of the Head, Neck, and Lung | withdrawn | N/A | 0 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Apr 12, 2024 | clinicaltrials |
| NCT06331975 | Radiomics and Radiogenomics of Non-small Cell Lung Cancer | completed | N/A | 91 | European Institute of OncologyOTHER | 1 | Mar 26, 2024 | clinicaltrials |
| NCT06020430 | Omitting CTV for Locally Advanced NSCLC Responded to Immunotherapy and Chemotherapy | recruiting | N/A | 134 | Hubei Cancer HospitalOTHER | 1 | Mar 15, 2024 | clinicaltrials |
| NCT06037733 | Primary Tumor Radiotherapy Omitting CTV for Patients With Advanced NSCLC Responded to Immunotherapy and Chemotherapy | recruiting | N/A | 134 | Hubei Cancer HospitalOTHER | 1 | Mar 15, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Dec 19, 2024source: clinicaltrials